An Indian company struck gold by making vital drugs affordable. But there’s a catch

Zee Laboratories’ medicines have failed tests repeatedly. So why are they still on shelves around the world?

By Priyanka Pulla, Andjela Milivojevic, Paul Eccles — in partnership with Context / Thomson Reuters Foundation

This article was originally published by The Bureau of Investigative Journalism.